185 related articles for article (PubMed ID: 16330906)
21. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients.
Brackbill ML; Stam MD; Schuller-Williams RV; Dhavle AA
Ann Pharmacother; 2007 Mar; 41(3):427-32. PubMed ID: 17311834
[TBL] [Abstract][Full Text] [Related]
22. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
23. B-type natriuretic peptide: spectrum of application. Nesiritide (recombinant BNP) for heart failure.
Fonarow GC
Heart Fail Rev; 2003 Oct; 8(4):321-5. PubMed ID: 14574051
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the initial hospitalization costs between the patients treated with dobutamine and the patients treated with amrinone for acute decompensated heart failure in a Japanese institute.
Komamura K; Matsuo H; Sasaki T
Value Health; 2008 Mar; 11 Suppl 1():S39-42. PubMed ID: 18387066
[TBL] [Abstract][Full Text] [Related]
26. Nesiritide: a review of its use in acute decompensated heart failure.
Keating GM; Goa KL
Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.
Burger AJ; Elkayam U; Neibaur MT; Haught H; Ghali J; Horton DP; Aronson D
Am J Cardiol; 2001 Jul; 88(1):35-9. PubMed ID: 11423055
[TBL] [Abstract][Full Text] [Related]
28. [Cost analysis of the treatment of acute decompensated heart failure. Levosimendan versus dobutamine].
Oliveira MT; Follador W; Martins ML; Canaviera R; Tsuji RL; Scipioni A; Barretto AC
Arq Bras Cardiol; 2005 Jul; 85(1):9-14. PubMed ID: 16041448
[TBL] [Abstract][Full Text] [Related]
29. Intravenous nesiritide in acute heart failure.
Knox MA; Dancy T; Mook W; Pschirer JJ
Am J Ther; 2005; 12(3):233-7. PubMed ID: 15891267
[TBL] [Abstract][Full Text] [Related]
30. Sustained use of nesiritide to aid in bridging to heart transplant.
Hill JA; Hsu K; Pauly DF; Schofield R; Aranda JM
Clin Cardiol; 2003 May; 26(5):211-4. PubMed ID: 12769247
[TBL] [Abstract][Full Text] [Related]
31. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery: a randomized, double-blind, placebo-controlled trial.
Costello JM; Dunbar-Masterson C; Allan CK; Gauvreau K; Newburger JW; McGowan FX; Wessel DL; Mayer JE; Salvin JW; Dionne RE; Laussen PC
Circ Heart Fail; 2014 Jul; 7(4):596-604. PubMed ID: 24906491
[TBL] [Abstract][Full Text] [Related]
32. Nesiritide Therapy Is Associated With Better Clinical Outcomes Than Dobutamine Therapy in Heart Failure.
Kong LG; Wang CL; Zhao D; Wang B
Am J Ther; 2017; 24(2):e181-e188. PubMed ID: 26164026
[TBL] [Abstract][Full Text] [Related]
33. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure.
Marius-Nunez AL; Heaney L; Fernandez RN; Clark WA; Ranganini A; Silber E; Denes P
Am Heart J; 1996 Oct; 132(4):805-8. PubMed ID: 8831370
[TBL] [Abstract][Full Text] [Related]
34. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
[TBL] [Abstract][Full Text] [Related]
35. Concomitant use of nesiritide and milrinone in decompensated congestive heart failure.
Smull DL; Jorde UP
Am J Health Syst Pharm; 2005 Feb; 62(3):291-5. PubMed ID: 15719588
[No Abstract] [Full Text] [Related]
36. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
Cleland JG; Takala A; Apajasalo M; Zethraeus N; Kobelt G
Eur J Heart Fail; 2003 Jan; 5(1):101-8. PubMed ID: 12559222
[TBL] [Abstract][Full Text] [Related]
37. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
[TBL] [Abstract][Full Text] [Related]
38. The costs of treating acute heart failure: an economic analysis of the SURVIVE trial.
de Lissovoy G; Fraeman K; Salon J; Chay Woodward T; Sterz R
J Med Econ; 2008; 11(3):415-29. PubMed ID: 19450096
[TBL] [Abstract][Full Text] [Related]
39. Nesiritide for the treatment of congestive heart failure.
Iyengar S; Feldman DS; Trupp R; Abraham WT
Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572
[TBL] [Abstract][Full Text] [Related]
40. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
